Trevi Therapeutics prices $150M stock offering; provides Haduvio trial updates

Trevi Therapeutics, Inc.

Offering of 11.6M shares at $13.00/sh; net proceeds ~$141.1M (or ~$162.4M if option exercised).
Cash, cash equivalents and marketable securities ~$171.8M as of March 31, 2026.
Cash runway extended through 2029, funding two Phase 3 IPF-cough trials and Phase 2b in non-IPF ILD and RCC.
First Phase 3 IPF trial starts Q2 2026; topline results expected H1 2028; second Phase 3 in H2 2026 with results H2 2027.
Phase 2b for RCC begins Q2 2026, topline results H2 2027.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Trevi Therapeutics, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC and Leerink Partners LLC, as representatives of the several underwriters valued at $13.00 per share (effective 2026-04-16).

Action: entry
Agreement: underwriting
Counterparty: Morgan Stanley & Co. LLC and Leerink Partners LLC, as representatives of the several underwriters
Value: $13.00 per share
Effective: 2026-04-16

Exact text from the filing

On April 16, 2026, Trevi Therapeutics, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC and Leerink Partners LLC, as representatives of the several underwriters (the “Underwriters”), relating to an underwritten offering (the “Offering”) of 11,600,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”).

View on SEC.gov

Browse all material agreements →

Trevi Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-160355

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.